“Impact of Bulky & Liposomal Secukinumab on Lymphocytes of Psoriatic Patients, to Determine the Improvement in Bioavailability of Secukinumab Nanolipo”, Am. J. Life Sci. Innov., vol. 4, no. 1, pp. 27–35, Jun. 2025, doi: 10.54536/ajlsi.v4i1.3268.